- Home
- CMPX vs DHF Comparison
CMPX vs DHF Comparison
Compare CMPX & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- DHF
- Stock Information
- Founded
- CMPX 2014
- DHF 1998
- Country
- CMPX United States
- DHF United States
- Employees
- CMPX N/A
- DHF N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- DHF Finance Companies
- Sector
- CMPX Health Care
- DHF Finance
- Exchange
- CMPX Nasdaq
- DHF Nasdaq
- Market Cap
- CMPX 206.3M
- DHF 187.7M
- IPO Year
- CMPX N/A
- DHF N/A
- Fundamental
- Price
- CMPX $1.42
- DHF $2.54
- Analyst Decision
- CMPX Strong Buy
- DHF
- Analyst Count
- CMPX 3
- DHF 0
- Target Price
- CMPX $7.67
- DHF N/A
- AVG Volume (30 Days)
- CMPX 421.2K
- DHF 451.1K
- Earning Date
- CMPX 11-12-2024
- DHF 01-01-0001
- Dividend Yield
- CMPX N/A
- DHF 7.65%
- EPS Growth
- CMPX N/A
- DHF N/A
- EPS
- CMPX N/A
- DHF N/A
- Revenue
- CMPX $850,000.00
- DHF N/A
- Revenue This Year
- CMPX N/A
- DHF N/A
- Revenue Next Year
- CMPX $610.48
- DHF N/A
- P/E Ratio
- CMPX N/A
- DHF N/A
- Revenue Growth
- CMPX N/A
- DHF N/A
- 52 Week Low
- CMPX $0.77
- DHF $2.06
- 52 Week High
- CMPX $2.34
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- CMPX 41.28
- DHF 35.38
- Support Level
- CMPX $1.44
- DHF $2.62
- Resistance Level
- CMPX $1.58
- DHF $2.62
- Average True Range (ATR)
- CMPX 0.12
- DHF 0.03
- MACD
- CMPX -0.01
- DHF -0.01
- Stochastic Oscillator
- CMPX 11.63
- DHF 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.